A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 Diabetes
Clinical trial NCT06567041 · COMPLETED
Trial details
- NCT number
- NCT06567041
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-07
- Primary completion
- 2025-12-10
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.